Navigation Links
Reportlinker Adds Global Anticoagulants Industry
Date:11/17/2010

lants by Product Segment - Oral Anticoagulants and

Injectable Anticoagulants (Unfractionated Heparin and Low

Molecular Weight Heparin) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 118

Table 37: German Historic Review for Anticoagulants by

Product Segment - Oral Anticoagulants and Injectable

Anticoagulants (Unfractionated Heparin and Low Molecular

Weight Heparin) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2000 through 2006

(includes corresponding Graph/Chart) 119

Table 38: German 11-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets for the Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 120

16c. ITALY 121

Market Analysis 121

Table 39: Italian Recent Past, Current & Future Analysis for

Anticoagulants by Product Segment - Oral Anticoagulants and

Injectable Anticoagulants (Unfractionated Heparin and Low

Molecular Weight Heparin) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 121

Table 40: Italian Historic Review for Anticoagulants by

Product Segment - Oral Anticoagulants and Injectable

Anticoagulants (Unfractionated Heparin and Low Molecular

Weight Heparin) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2000 through 2006

(includes corresponding Graph/Chart) 122

Table 41: Italian 11-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectabl
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Missouri (PRWEB) December 23, 2014 GMO ... Swiss biotechnology company, Syngenta, are in the process of ... proceedings. The consolidated case is In Re: Syngenta AG ... U.S. District Court for the District of Kansas. , ... has been handed over to U.S. District Judge John ...
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
(Date:12/22/2014)... The Center for Professional Innovation ... training across the life sciences industry, has partnered with ... to provide the organization's members with discounted classroom courses, ... the more than 350 sessions across 80 course titles. ... when registering for a public course at ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... Md., Oct. 12 Sequella, Inc., a clinical-stage ... treat life-threatening infectious diseases, today announced that it ... (SBIR) grant from the National Institutes of Health ... (NIAID) for the development of SQ641, Sequella,s lead ...
... Calif., Oct. 12 Raptor Pharmaceutical Corp. ("Raptor" or ... from the completed treatment phase of its open-label Phase ... in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive ... 5% of the U.S. population. At the completion of ...
... , ... singer, Cynthia Basinet petitions the United Nations Sixty-fourth General Assembly Fourth Committee on behalf ... ... and singer, Cynthia Basinet petitions the United Nations Sixty-fourth General Assembly Fourth Committee on ...
Cached Biology Technology:Sequella Obtains Funding to Continue Expansion of its Anti-infectives Pipeline 2Sequella Obtains Funding to Continue Expansion of its Anti-infectives Pipeline 3Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 2Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 3Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 5Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 6Actress and Singer, Cynthia Basinet Petitions United Nations 2
(Date:12/22/2014)... , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... entertainer and security consultant, Apollo Robbins for ... smart wallet.  Apollo Robbins ... 7 th , 2015, demonstrating some of his famous ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics ... pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred ... has served as a meeting place for peoples from ... the ongoing mixing of peoples with African, European, and ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... Vertebral fractures are a common cause of ... powerful predictors of future spine and hip fractures. ... simply fail to recognize vertebral fractures in their ... intervention is often not initiated. The Vertebral ...
... CHICAGO, IL (May 8, 2011) Research being ... individuals for hepatitis C based on age instead of ... well as prevent liver disease. Additionally, the rate of ... disease and type 2 diabetes is relatively low, and ...
... the Faculty of Medicine & Dentistry at the University ... kill neurons. This finding is significant because a specific ... medical community as a potential treatment for MS and ... post-doctoral fellow, Yohannes Haile, both from the Division of ...
Cached Biology News:New IOF teaching tool helps health professionals identify vertebral fractures 2Strides in identifying and improving screening practices and treatment for liver diseases 2Discovery demonstrates potential MS therapy could kill brain cells 2
Mouse monoclonal antibody raised against a partial recombinant ST3GAL2. NCBI Entrez Gene ID = ST3GAL2...
... Apoptosis is an evolutionarily conserved form of ... process. The central component of this ... called caspases. These enzymes participate in ... in response to pro-apoptotic signals and result ...
... DNA Visualizer Extraction Kit is manufactured for ... DNA damage byexposure to UV light. The ... is often used for DNA-cloning work. The ... bromide and exposure of UV light damages ...
...
Biology Products: